Mice with conditional loss of FXN in the heart develop cardiac hypertrophy as early as 5 weeks of age, followed by transition to dilated cardiomyopathy and heart failure by approximately 8 weeks of age [30]. The gene discussed is FXN; the disease is cardiac hypertrophy.